Skip to main content
. 2018 Jan 31;3(3):14–22. doi: 10.1001/jamacardio.2017.5205

Figure 4. Associations of Omega-3 Fatty Acids With Fatal and Nonfatal Vascular Events, by Trial Design.

Figure 4.

Symbols and conventions as in Figure 1. Heterogeneity between trial designs (χ21 in all cases) was 1.05 (P = .31) for nonfatal myocardial infarction, 3.26 (P = .07) for coronary heart disease death, and 4.81 (P = .03) for any coronary heart disease.